Research Desk Line-up: Middleby Post Earnings Coverage
LONDON, UK / ACCESSWIRE / August 16, 2017 /Pro-Trader Daily has just published a free post-earnings coverage on Xylem Inc. (NYSE: XYL), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=XYL, following the Company's release of its second quarter fiscal 2017 results on August 01, 2017. The water and wastewater treatment Company outperformed earnings expectations and also raised it earnings guidance for fiscal year 2017. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:
Get more of our free earnings reports coverage from other constituents of the Diversified Machinery industry. Pro-TD has currently selected The Middleby Corporation (NASDAQ: MIDD) for due-diligence and potential coverage as the Company reported net sales and earnings for Q2 2017 which ended on July 01, 2017. Register for a free membership today, and be among the early birds that get access to our report on Middleby when we publish it.
At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on XYL; also brushing on MIDD. With the links below you can directly download the report of your stock of interest free of charge at:
For the quarter ended June 30, 2017, Xylem's revenue, including the contribution from its Sensus business, was $1.16 billion, up 25% compared to revenue of $932 million in Q2 2016. Xylem's pro-forma organic revenue, which includes Sensus, grew more than 1% in the reported quarter. The Company's revenue numbers fell short of analysts' estimates of $1.17 billion.
During Q2 2017, Xylem's reported operating margin increased 20 basis points to 11.9% and adjusted operating margin was 13.3%. Excluding the negative impact of purchase accounting amortization related to the Sensus' acquisition, the adjusted operating margin expanded by 100 basis points on a y-o-y basis.
Xylem reported net income of $99 million, or $0.55 per diluted share, in Q2 2017 compared to net income of $71 million, or $0.39 per diluted share. The Company delivered adjusted net income of $106 million, or $0.59 per share, in the quarter, a 23% increase on a y-o-y basis. Xylem's bottom-line beat Wall Street's earnings estimate of $0.57 per share.
During Q2 2017 Xylem's Water Infrastructure segment revenue was $482 million, up 1% organically on a y-o-y basis. Strong industrial sector growth was fueled by dewatering demand in the construction industry as well as improved conditions in mining and oil and gas. For the reported quarter, the division's operating income was $74 million, while adjusted operating income for the segment, which excludes $5 million of restructuring and realignment costs, was $79 million, reflecting a 10% gain on a y-o-y basis. During Q2 2017, reported operating margin for the Water Infrastructure segment was 15.4%, reflecting a 180-basis-point increase on a y-o-y basis, while adjusted operating margin increased 150 basis points to 16.4% due to benefits from global procurement and continuous improvement initiatives as well as operating leverage on volume growth.
For Q2 2017, Xylem's Applied Water segment generated revenue of $361 million, reflecting 1% growth y-o-y on an organic basis. The segment's reported operating income was $49 million, down 4% on a y-o-y basis, while adjusted operating income remained flat on a y-o-y basis at $54 million. During the reported quarter, Applied Water segment reported operating margin was 13.6%, down 30 basis points over the prior year's same period, and adjusted operating margin increased 20 basis points to 15% as cost reductions and productivity initiatives more than offset inflation.
During Q2 2017, Xylem's Sensus & Analytics segment recorded revenue of $321 million, up 2% on a pro-forma organic basis over the prior year's corresponding period. The Sensus business delivered operating income of $29 million, including $5 million of restructuring and acquisition-related costs. Excluding those costs, adjusted operating income for the segment was $34 million, with an adjusted operating margin of 10.6%, which grew 210 basis points primarily due to the addition of higher operating margins from Sensus.
Xylem closed the quarter with a cash balance of $288 million. The Company's free cash flow in the reported quarter increased approximately 20% to $70 million on a y-o-y basis. Xylem's free cash flow conversion was 56% for H1 2017, which is on track with the Company's expectations to deliver greater than 110% conversion for the full year.
During Q2 2017, Xylem invested $34 million in capital expenditures and returned $52 million to its shareholders through dividends and share repurchases, of which $21 million was for share repurchases to manage dilution.
For full year 2017, Xylem is forecasting revenue in the range of $4.65 billion to $4.70 billion, up 24% to 25%. On a pro-forma organic basis, Xylem projects revenue growth of 3% to 4%.
For FY17, Xylem's adjusted operating margin is expected to be in the range of 13.2% to 13.7%. The Company increased its forecast for full-year earnings to reflect its updated assumption for foreign exchange impact. The Company now expects to deliver adjusted earnings per share of $2.30 to $2.40, which represents an increase of 13% to 18% from its 2016 adjusted results.
At the closing bell, on Tuesday, August 15, 2017, Xylem's stock marginally slipped 0.03%, ending the trading session at $59.86. A total volume of 706.57 thousand shares have exchanged hands. The Company's stock price surged 15.63% in the last three months, 25.62% in the past six months, and 18.96% in the previous twelve months. Moreover, the stock rallied 20.88% since the start of the year. The stock is trading at a PE ratio of 38.87 and has a dividend yield of 1.20%. The stock currently has a market cap of $10.72 billion.
Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (917) 341.4653
Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
© 2017 Accesswire. All Rights Reserved.